
Specialized Expertise to Mitigate Challenges
in Dermatology Clinical Trials
Dermatological conditions are among the most common medical concerns, encompassing both common conditions such as acne, atopic dermatitis, psoriasis, and hair loss, as well as rare skin diseases such as pemphigoid, hidradenitis suppurativa, and congenital ichthyosis. These conditions present significant challenges for patients, including the development of sequelae such as chronic pain, itching, scarring, and often stigmatization. Advancing the development of more effective and safer treatments for these skin diseases has the potential to enhance the quality of life for affected patients.
The Medpace dermatology team has a deep understanding of the complexity of managing clinical trials in a broad range of dermatologic conditions, including in pediatrics and rare diseases. For over 30 years, Sponsors across emerging biotechnology and global pharmaceutical companies have trusted Medpace to lead their clinical development.
Making the Complex Seamless®
in Global Dermatology Clinical Trials
The successful execution of dermatology clinical trials requires a thorough understanding of the current drug development landscape, the clinical progression of dermatologic diseases, and the complexities involved in evaluating specific skin diseases.
Partner with Medpace to proactively anticipate challenges in dermatology clinical trials, while creatively approaching study design and patient recruitment—especially for rare and pediatric populations. Our extensive expertise ensures the successful development and execution of your clinical trial across key dermatological indications, including:
- Psoriasis
- Atopic Dermatitis
- Eczema
- Onychomycosis
- Wound Care
- Acne
- Vitiligo
- Burns
- Alopecia Areata
- Androgenetic Alopecia
- Epidermolysis Bullosa
- Superficial Skin Infections
- Seborrheic Dermatitis
- Congenital Ichthyosis
- Rare Genetic Skin Diseases
- Prurigo Nodularis
- Hidradenitis Suppurativa
- Rosacea
- Autoimmune Bullous Skin Disease
Whitepaper
Dermatology Clinical Trials: Best Practices in Digital Photography
Dermatology Clinical Trial Experts
Be confident in the rigorous design and conduct of your upcoming dermatology clinical trial with guidance from our global, cross-functional team comprised of Medpace physicians, imaging specialists, and operational and regulatory experts. Leverage our team’s 140+ years of combined dermatology experience and strong relationships with investigators and top-performing sites to accelerate your dermatology clinical trial.
Our in-house physicians have the expertise to provide hands-on leadership throughout a clinical trial across many indications, including inflammatory skin diseases, autoimmune skin diseases, genetic skin diseases, and skin and soft tissue infections. Additionally, our operational team, including clinical trial managers and project coordinators, are therapeutically aligned to provide specialized training to sites and help mitigate challenges.
Integrated Services
Streamline dermatology clinical trials with a full-service, single-vendor outsourcing strategy. Our comprehensive CRO services are supported by our wholly-owned Central Laboratories, Bioanalytical Lab, Imaging and ECG Core Lab, and Phase I Unit, as well as ClinTrak®, a Clinical Trial Management System that ties all study data together in a single platform.
Dermatologic Imaging
Medpace Core Labs provides comprehensive imaging, wearable biosensor, and pathology expertise to ensure that these components are seamlessly integrated into your trial. Our core lab is supported by an integrated dermatology team comprised of scientists, clinicians, technologists, project managers and coordinators who provide guidance and oversight to dermatology clinical trials. Our imaging project managers have decades of experience in managing teams and processes for imaging assessments in clinical trials, providing first-hand knowledge relative to the challenges of these studies to ensure efficient delivery.

Wholly-Owned Central Laboratories
Medpace Central Labs provide consistency in methods and instrumentation across wholly-owned and purpose-built laboratories located in the US, Europe, China and Singapore. We offer safety testing as well as a wide range biomarker assays and can quickly establish and validate novel assays as needed. The team of hands-on laboratory PhD scientists are actively engaged with your study team throughout the entire clinical development process and collaborate with laboratory technologists and the project management team to seamlessly execute your trial.


Leverage Full-Service Solutions for Early-Phase Studies
The Medpace Phase I Unit provides an integrated, scientifically driven approach to early-phase clinical development. The Phase I Unit draws on the extensive expertise of the Medpace CRO to provide a full range of early-phase clinical research services, including regulatory consulting for early-phase development protocol design and writing, development of innovative processes for complex studies, pharmacokinetic and translational medicine consulting, project management, data management, and biostatistics.